As Poland’s largest manufacturer of medicines, including hospital drugs used in the treatment of covid complications, we are aware of the related responsibility. That is why, during the pandemic, we focused primarily on ensuring continuity of our production, tackling numerous challenges to make sure that the necessary medicines remain available to Polish patients. This approach is aligned with the objectives of our CSR strategy, which is based on the following pillars: serving the patients and the community, ethical conduct of business, innovation and advancing knowledge.
People are in the center of what we do. The report provides specific examples of:
– How we educate and what health prevention activities we carry out
– What ethical principles guide our day to day operations
– How we make life easier by using new technologies
– How we care for our employees
– Our actions for the climate and the environment
We would like to thank everyone who contributed to this report by participating in the survey of our social stakeholders. We do hope that the publication will meet your expectations.
The report is available here>>
The Corporate Social Responsibility Report of the Polpharma Group in Poland 2019-2020 has been prepared in accordance with standards for sustainability reporting The GRI Standards Core option and reviewed independently.